IFNγ levels are relatively high in the CNS during MS relapse and peak clinical EAE, when there is a large influx of activated peripheral immune cells, suggesting that astrocyte viability is likely to decrease during those periods [84]. This evidence concerns the gene IFNG and myeloid sarcoma.